Published in Stat Med on December 30, 2002
Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes (2009) 2.05
Comparing higher order models for the EORTC QLQ-C30. Qual Life Res (2011) 1.60
Relationship of family caregiver burden with quality of care and psychopathology in a sample of Arab subjects with schizophrenia. BMC Psychiatry (2010) 1.20
Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer. J Thorac Oncol (2009) 1.12
Pretreatment lifestyle behaviors as survival predictors for patients with nasopharyngeal carcinoma. PLoS One (2012) 1.04
Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat (2011) 1.02
Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer? Health Qual Life Outcomes (2011) 0.99
Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database. Qual Life Res (2009) 0.98
Profile of subjective quality of life and its correlates in a nation-wide sample of high school students in an Arab setting using the WHOQOL-Bref. BMC Psychiatry (2011) 0.88
Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy. Br J Cancer (2010) 0.87
Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients' survival. Health Qual Life Outcomes (2014) 0.86
Genome-wide association interaction analysis for Alzheimer's disease. Neurobiol Aging (2014) 0.84
Characteristics of subjects with comorbidity of symptoms of generalized anxiety and major depressive disorders and the corresponding threshold and subthreshold conditions in an Arab general population sample. Med Sci Monit (2012) 0.80
Renal replacement therapy in the ICU: comparison of clinical features and outcomes of patients with acute kidney injury and dialysis-dependent end-stage renal disease. Clin Exp Nephrol (2014) 0.80
Practical aspects of genome-wide association interaction analysis. Hum Genet (2014) 0.79
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma. Oncologist (2014) 0.79
Using patient-reported health status to improve prognostic assessment in patients with acute myeloid leukemia: current challenges and future applications. Haematologica (2013) 0.78
Factors associated with fatigue after surgery in women with early-stage invasive breast cancer. Oncologist (2013) 0.76
Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data. BMC Cancer (2017) 0.75
A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy. BMC Med Inform Decis Mak (2012) 0.75
Discovering main genetic interactions with LABNet LAsso-based network inference. PLoS One (2014) 0.75
Value of quality of life analysis in liver cancer: A clinician's perspective. World J Hepatol (2017) 0.75
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med (2002) 17.04
A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol (2010) 7.70
The prevention and treatment of missing data in clinical trials. N Engl J Med (2012) 6.92
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet (2006) 6.67
International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol (2011) 5.95
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol (2008) 5.56
Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol (2004) 5.38
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol (2011) 4.25
The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol (2008) 3.14
Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol (2002) 2.98
European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol (2013) 2.93
A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol (2006) 2.80
Maintenance bacillus Calmette-Guérin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence. Eur Urol (2013) 2.78
European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol (2011) 2.70
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol (2009) 2.64
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother (2011) 2.58
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst (2011) 2.56
Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol (2008) 2.55
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. J Clin Oncol (2011) 2.50
Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol (2005) 2.26
Graphical exploration of gene expression data: a comparative study of three multivariate methods. Biometrics (2003) 2.20
Missing data methods in longitudinal studies: a review. Test (Madr) (2009) 2.15
Type I and Type II error under random-effects misspecification in generalized linear mixed models. Biometrics (2007) 2.11
Assessing and interpreting treatment effects in longitudinal clinical trials with missing data. Biol Psychiatry (2003) 2.03
The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer (2005) 1.97
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer (2008) 1.95
What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol (2004) 1.89
An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer (2010) 1.84
Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpoints. Biometrics (2004) 1.80
Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med (2005) 1.77
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. J Clin Oncol (2012) 1.76
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol (2007) 1.72
Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials. Clin Trials (2005) 1.70
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma. J Clin Oncol (2013) 1.62
Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer (2007) 1.62
The use of score tests for inference on variance components. Biometrics (2003) 1.48
Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors? Eur Urol (2010) 1.47
Do quality-of-life randomized clinical trials support clinicians in their decision-making? J Clin Oncol (2002) 1.45
Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma. Eur Urol (2013) 1.45
A latent-class mixture model for incomplete longitudinal Gaussian data. Biometrics (2007) 1.45
The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA. Clin Trials (2004) 1.45
A local influence approach applied to binary data from a psychiatric study. Biometrics (2003) 1.40
Strategies to fit pattern-mixture models. Biostatistics (2002) 1.38
Last observation carried forward: a crystal ball? J Biopharm Stat (2009) 1.36
Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer. Stat Med (2004) 1.36
Evaluation of chromogenic media for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2010) 1.30
Perinatal outcome of 12,021 singleton and 3108 twin births after non-IVF-assisted reproduction: a cohort study. Hum Reprod (2005) 1.29
Review on quality of life issues in patients with primary brain tumors. Oncologist (2010) 1.24
Model averaging using fractional polynomials to estimate a safe level of exposure. Risk Anal (2007) 1.23
The analysis of multivariate longitudinal data: a review. Stat Methods Med Res (2012) 1.22
Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? Eur J Cancer (2005) 1.20
Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology (2003) 1.17
Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study. J Clin Oncol (2004) 1.17
A unified approach to multi-item reliability. Biometrics (2010) 1.16
Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22. Int J Radiat Oncol Biol Phys (2012) 1.15
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer (2010) 1.15
International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases. Cancer (2011) 1.14
Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials. Cancer (2003) 1.14
The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer. Eur Urol (2009) 1.14
A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales. J Clin Epidemiol (2008) 1.12
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials. J Clin Oncol (2005) 1.11
Assessing HRQOL: a neglected issue for high-grade glioma. Lancet Oncol (2003) 1.11
Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression. Health Qual Life Outcomes (2010) 1.11
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer (2013) 1.10
Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. J Clin Oncol (2004) 1.09
A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards model. Stat Med (2005) 1.09
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother (2011) 1.08
Progression-free survival rate as primary end point for phase II cancer clinical trials: application to mesothelioma--The EORTC Lung Cancer Group. J Clin Oncol (2006) 1.07
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer (2007) 1.07
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer (2008) 1.07
Multiple-imputation-based residuals and diagnostic plots for joint models of longitudinal and survival outcomes. Biometrics (2009) 1.05
Blinking suppresses the neural response to unchanging retinal stimulation. Curr Biol (2005) 1.05
European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009). J Antimicrob Chemother (2011) 1.04
Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, The Netherlands and the United Kingdom. Eur J Cancer (2007) 1.03
Fatigue and quality of life: lessons from the real world. Oncologist (2003) 1.02
Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13). Psychooncology (2012) 1.01
Applying concepts of generalizability theory on clinical trial data to investigate sources of variation and their impact on reliability. Biometrics (2005) 1.00
Surrogate marker evaluation from an information theory perspective. Biometrics (2007) 1.00
Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials. J Clin Oncol (2011) 1.00
European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009). J Antimicrob Chemother (2011) 0.99
Selection models and pattern-mixture models to analyse longitudinal quality of life data subject to drop-out. Stat Med (2002) 0.99
Using the continual reassessment method: lessons learned from an EORTC phase I dose finding study. Eur J Cancer (2006) 0.99
The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database. J Clin Epidemiol (2008) 0.98
Applying linear mixed models to estimate reliability in clinical trial data with repeated measurements. Control Clin Trials (2004) 0.98
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol (2007) 0.97
European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009). J Antimicrob Chemother (2011) 0.97
Can radical prostatectomy benefit patients despite the presence of regional metastases? Eur Urol (2010) 0.97
Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2010) 0.97